Tapewire

Nasdaq · USD

SLSN

SOLESENCE, INC.

Export transactions ↓
Tapewire entity
7041
SEC CIK
0000883107
Parsed reports
187

Last 12 months

Inside the activity.

7 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202550
Dec 202520
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 17, 2022 Filed Jun 22, 2022 22:43 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock 25,000 $0.30 $7,500.00
Disclosure

SEC source: 0001209191-22-038759 · doc4.xml · nonDerivative · entry 3

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

F1 · price: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 21:01 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock (right to purchase) · Derivative 12,485 $0.30 Strike: $0.30 $3,745.50
Disclosure

SEC source: 0001209191-22-037945 · doc4.xml · derivative · entry 8

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,560

Underlying: Common Stock · 56,045 shares

Expires 2022-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 21:01 UTC
JANKOWSKI JESSDirector · President, CEO
SaleCommon Stock 12,485 $3.00 $37,455.00
Disclosure

SEC source: 0001209191-22-037945 · doc4.xml · nonDerivative · entry 6

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,000

Read SEC document
June 15, 2022 Filed Jun 17, 2022 21:01 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock 12,485 $0.30 $3,745.50
Disclosure

SEC source: 0001209191-22-037945 · doc4.xml · nonDerivative · entry 5

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,485

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

Read SEC document
June 13, 2022 Filed Jun 17, 2022 21:01 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock (right to purchase) · Derivative 7,800 $0.30 Strike: $0.30 $2,340.00
Disclosure

SEC source: 0001209191-22-037945 · doc4.xml · derivative · entry 7

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,045

Underlying: Common Stock · 63,845 shares

Expires 2022-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

F3 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Read SEC document
June 13, 2022 Filed Jun 17, 2022 21:01 UTC
JANKOWSKI JESSDirector · President, CEO
SaleCommon Stock 7,800 $3.00 $23,400.00
Disclosure

SEC source: 0001209191-22-037945 · doc4.xml · nonDerivative · entry 4

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,000

Read SEC document
June 13, 2022 Filed Jun 17, 2022 21:01 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock 7,800 $0.30 $2,340.00
Disclosure

SEC source: 0001209191-22-037945 · doc4.xml · nonDerivative · entry 3

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,800

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: This transaction was communicated to the reporting person on June 17th due to a clerical error.

F2 · price: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

Read SEC document
June 09, 2022 Filed Jun 13, 2022 21:16 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock (right to purchase) · Derivative 21,100 $0.30 Strike: $0.30 $6,330.00
Disclosure

SEC source: 0001209191-22-036393 · doc4.xml · derivative · entry 5

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,845

Underlying: Common Stock · 84,945 shares

Expires 2022-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

F2 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Read SEC document
June 09, 2022 Filed Jun 13, 2022 21:16 UTC
JANKOWSKI JESSDirector · President, CEO
SaleCommon Stock 21,100 $3.01 $63,511.00
Disclosure

SEC source: 0001209191-22-036393 · doc4.xml · nonDerivative · entry 4

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,000

Read SEC document
June 09, 2022 Filed Jun 13, 2022 21:16 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock 21,100 $0.30 $6,330.00
Disclosure

SEC source: 0001209191-22-036393 · doc4.xml · nonDerivative · entry 3

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 22:16 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock (right to purchase) · Derivative 1,500 $0.30 Strike: $0.30 $450.00
Disclosure

SEC source: 0001209191-22-035173 · doc4.xml · derivative · entry 11

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,945

Underlying: Common Stock · 86,445 shares

Expires 2022-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

F2 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 22:16 UTC
JANKOWSKI JESSDirector · President, CEO
SaleCommon Stock 1,500 $3.00 $4,500.00
Disclosure

SEC source: 0001209191-22-035173 · doc4.xml · nonDerivative · entry 8

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,000

Read SEC document
June 08, 2022 Filed Jun 8, 2022 22:16 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock 1,500 $0.30 $450.00
Disclosure

SEC source: 0001209191-22-035173 · doc4.xml · nonDerivative · entry 7

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

Read SEC document
June 07, 2022 Filed Jun 8, 2022 22:16 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock (right to purchase) · Derivative 100 $0.30 Strike: $0.30 $30.00
Disclosure

SEC source: 0001209191-22-035173 · doc4.xml · derivative · entry 10

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100 shares

Expires 2022-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

F2 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Read SEC document
June 07, 2022 Filed Jun 8, 2022 22:16 UTC
JANKOWSKI JESSDirector · President, CEO
SaleCommon Stock 100 $3.00 $300.00
Disclosure

SEC source: 0001209191-22-035173 · doc4.xml · nonDerivative · entry 6

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,000

Read SEC document
June 07, 2022 Filed Jun 8, 2022 22:16 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock 100 $0.30 $30.00
Disclosure

SEC source: 0001209191-22-035173 · doc4.xml · nonDerivative · entry 5

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 22:16 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock (right to purchase) · Derivative 11,455 $0.30 Strike: $0.30 $3,436.50
Disclosure

SEC source: 0001209191-22-035173 · doc4.xml · derivative · entry 9

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,455 shares

Expires 2022-08-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

F2 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 22:16 UTC
JANKOWSKI JESSDirector · President, CEO
SaleCommon Stock 11,455 $3.03 $34,708.65
Disclosure

SEC source: 0001209191-22-035173 · doc4.xml · nonDerivative · entry 4

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,000

Read SEC document
June 06, 2022 Filed Jun 8, 2022 22:16 UTC
JANKOWSKI JESSDirector · President, CEO
Exercise / conversionCommon Stock 11,455 $0.30 $3,436.50
Disclosure

SEC source: 0001209191-22-035173 · doc4.xml · nonDerivative · entry 3

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,455

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These options were set to expire on 08/07/2022. Under the Company's Policy on Insider Trading, all Nanophase employees will enter a blackout period on 06/25/2022, which will not end until three working days after the Company releases Q22022 earnings.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 18:07 UTC GrantCommon Stock (right to purchase) · Derivative 15,000 $4.17 Strike: $4.17 $62,550.00
Disclosure

SEC source: 0001209191-21-071587 · doc4.xml · derivative · entry 19

SIEGEL RICHARD W · CIK 0001195154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-12-28

F5 · derivative.exercise_date: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 18:06 UTC GrantCommon Stock (option to purchase) · Derivative 15,000 $4.17 Strike: $4.17 $62,550.00
Disclosure

SEC source: 0001209191-21-071586 · doc4.xml · derivative · entry 2

Beres Laura M · CIK 0001826480 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-12-28

F1 · derivative.exercise_date: Beginning on this date, and subject to certain restrictions, options vest in three equal annual installments.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 18:04 UTC GrantCommon Stock (right to purchase) · Derivative 20,000 $4.17 Strike: $4.17 $83,400.00
Disclosure

SEC source: 0001209191-21-071585 · doc4.xml · derivative · entry 19

WHITMORE R JANET · CIK 0001173970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2028-12-28

F5 · derivative.exercise_date: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 17:43 UTC
Cureton KevinChief Operating Officer
GrantCommon Stock (right to purchase) · Derivative 90,000 $4.17 Strike: $4.17 $375,300.00
Disclosure

SEC source: 0001209191-21-071579 · doc4.xml · derivative · entry 9

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2028-12-28

Read SEC document
December 28, 2021 Filed Dec 30, 2021 17:43 UTC
JANKOWSKI JESSDirector · President, CEO
GrantCommon Stock (right to purchase) · Derivative 90,000 $4.17 Strike: $4.17 $375,300.00
Disclosure

SEC source: 0001209191-21-071578 · doc4.xml · derivative · entry 12

JANKOWSKI JESS · CIK 0001184478 · Director · President, CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2028-12-28

F2 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal installments.

Read SEC document
December 28, 2021 Filed Jul 25, 2022 20:00 UTC GrantCommon Stock (right to purchase) · Derivative 15,000 $4.17 Strike: $4.17 $62,550.00
Disclosure

SEC source: 0001209191-22-043088 · doc4.xml · derivative · entry 20

SIEGEL RICHARD W · CIK 0001195154 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-12-28

F5 · derivative.exercise_date: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments.

Read SEC document
December 28, 2021 Filed Jul 25, 2022 20:00 UTC GrantCommon Stock (right to purchase) · Derivative 20,000 $4.17 Strike: $4.17 $83,400.00
Disclosure

SEC source: 0001209191-22-043087 · doc4.xml · derivative · entry 20

WHITMORE R JANET · CIK 0001173970 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2028-12-28

F5 · derivative.exercise_date: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments.

Read SEC document
December 21, 2021 Filed Dec 23, 2021 21:28 UTC PurchaseCommon Stock 7,731,573 $4.19 $32,361,271.95
Disclosure

SEC source: 0000933430-21-000008 · primary_doc.xml · nonDerivative · entry 2

WHITMORE BRADFORD T · CIK 0000933430 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Strandler, LLC

Disclosed balance after: 7,731,573

F1 · ownership.direct: As sole manager and sole voting member of Strandler, LLC, Bradford T. Whitmore is an indirect beneficial owner of 7,731,573 shares of Common Stock.

Read SEC document
December 21, 2021 Filed Dec 23, 2021 21:28 UTC SaleCommon Stock 7,731,573 $4.19 $32,361,271.95
Disclosure

SEC source: 0000933430-21-000008 · primary_doc.xml · nonDerivative · entry 1

WHITMORE BRADFORD T · CIK 0000933430 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,893,717

Read SEC document
November 30, 2021 Filed Dec 1, 2021 01:09 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock (right to purchase) · Derivative 25,000 $0.52 Strike: $0.52 $13,000.00
Disclosure

SEC source: 0001209191-21-067223 · doc4.xml · derivative · entry 8

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 50,000 shares

Expires 2024-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Following the recently reported exercise of 12,393 shares (11/24/21), and the 2nd exercise of 12,607 shares (11/26/21, reported above) this line item represents the 3rd exercise, of 25,000 shares of the total initial grant of 75,000 shares, leaving a balance of 25,000 shares remaining relating to this grant.

F2 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Read SEC document
November 30, 2021 Filed Dec 1, 2021 01:09 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock (right to purchase) · Derivative 24,000 $0.42 Strike: $0.42 $9,960.00
Disclosure

SEC source: 0001209191-21-067223 · doc4.xml · derivative · entry 6

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,000 shares

Expires 2023-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Following recently reported exercises of 11,668 (11/22/21) and 12,332 (11/24/21) shares, this line item represents the 3rd exercise, of 24,000 shares of the total initial grant of 48,000 shares, leaving a balance of 0 shares remaining relating to this grant.

F2 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Read SEC document
November 30, 2021 Filed Dec 1, 2021 01:09 UTC
Cureton KevinChief Operating Officer
SaleCommon Stock 23,829 $3.79 $90,311.91
Disclosure

SEC source: 0001209191-21-067223 · doc4.xml · nonDerivative · entry 5

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,821

Read SEC document
November 30, 2021 Filed Dec 1, 2021 01:09 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock 25,000 $0.52 $13,000.00
Disclosure

SEC source: 0001209191-21-067223 · doc4.xml · nonDerivative · entry 4

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,650

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2021 Filed Dec 1, 2021 01:09 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock 24,000 $0.42 $9,960.00
Disclosure

SEC source: 0001209191-21-067223 · doc4.xml · nonDerivative · entry 3

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,650

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 26, 2021 Filed Dec 1, 2021 01:09 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock · Derivative 12,607 $0.52 Strike: $0.52 $6,555.64
Disclosure

SEC source: 0001209191-21-067223 · doc4.xml · derivative · entry 7

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,607 shares

Expires 2023-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Following the recently reported exercise of 12,393 shares (11/24/21), this line item represents the 2nd exercise, of 12,607 shares of a total initial grant of 75,000 shares, leaving a balance of 50,000 shares remaining relating to this grant, prior to the 11/30/21 exercise reported below.

F2 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Read SEC document
November 26, 2021 Filed Dec 1, 2021 01:09 UTC
Cureton KevinChief Operating Officer
SaleCommon Stock 12,607 $3.50 $44,124.50
Disclosure

SEC source: 0001209191-21-067223 · doc4.xml · nonDerivative · entry 2

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,650

Read SEC document
November 26, 2021 Filed Dec 1, 2021 01:09 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock 12,607 $0.52 $6,555.64
Disclosure

SEC source: 0001209191-21-067223 · doc4.xml · nonDerivative · entry 1

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,257

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 24, 2021 Filed Nov 24, 2021 21:52 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock (right to purchase) · Derivative 12,393 $0.52 Strike: $0.52 $6,444.36
Disclosure

SEC source: 0001209191-21-066811 · doc4.xml · derivative · entry 8

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,607

Underlying: Common Stock · 75,000 shares

Expires 2024-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Read SEC document
November 24, 2021 Filed Nov 24, 2021 21:52 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock (right to purchase) · Derivative 12,332 $0.42 Strike: $0.42 $5,117.78
Disclosure

SEC source: 0001209191-21-066811 · doc4.xml · derivative · entry 7

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 36,332 shares

Expires 2023-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: This line item represents the 2nd sale, of 12,332 shares of a total initial grant of 48,000 shares, leaving a balance of 24,000 shares remaining relating to this grant.

F3 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Read SEC document
November 24, 2021 Filed Nov 24, 2021 21:52 UTC
Cureton KevinChief Operating Officer
SaleCommon Stock 24,725 $3.77 $93,213.25
Disclosure

SEC source: 0001209191-21-066811 · doc4.xml · nonDerivative · entry 5

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,650

Read SEC document
November 24, 2021 Filed Nov 24, 2021 21:52 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock 12,393 $0.52 $6,444.36
Disclosure

SEC source: 0001209191-21-066811 · doc4.xml · nonDerivative · entry 4

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,375

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 24, 2021 Filed Nov 24, 2021 21:52 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock 12,332 $0.42 $5,117.78
Disclosure

SEC source: 0001209191-21-066811 · doc4.xml · nonDerivative · entry 3

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,982

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:52 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock (right to purchase) · Derivative 11,668 $0.42 Strike: $0.42 $4,842.22
Disclosure

SEC source: 0001209191-21-066811 · doc4.xml · derivative · entry 6

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,668 shares

Expires 2023-02-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This line item represents the 1st sale of 11,668 shares of a total grant of 48,000 shares, leaving a balance of 36,332 shares remaining relating to this grant.

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:52 UTC
Cureton KevinChief Operating Officer
SaleCommon Stock 11,668 $3.92 $45,743.23
Disclosure

SEC source: 0001209191-21-066811 · doc4.xml · nonDerivative · entry 2

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,650

Read SEC document
November 22, 2021 Filed Nov 24, 2021 21:52 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock 11,668 $0.42 $4,842.22
Disclosure

SEC source: 0001209191-21-066811 · doc4.xml · nonDerivative · entry 1

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2021 Filed Sep 16, 2021 22:07 UTC
Cureton KevinChief Operating Officer
SaleCommon Stock 1,200 $2.26 $2,712.00
Disclosure

SEC source: 0001209191-21-056457 · doc4.xml · nonDerivative · entry 5

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,650

F2 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. The sales reported herein were effected in order to satisfy the costs of exercise and the required income tax withholdings.

Read SEC document
September 16, 2021 Filed Sep 16, 2021 22:07 UTC
Cureton KevinChief Operating Officer
SaleCommon Stock 17,000 $2.22 $37,740.00
Disclosure

SEC source: 0001209191-21-056457 · doc4.xml · nonDerivative · entry 4

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,850

F2 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. The sales reported herein were effected in order to satisfy the costs of exercise and the required income tax withholdings.

Read SEC document
September 15, 2021 Filed Sep 16, 2021 22:07 UTC
Cureton KevinChief Operating Officer
SaleCommon Stock 5,350 $2.30 $12,305.00
Disclosure

SEC source: 0001209191-21-056457 · doc4.xml · nonDerivative · entry 3

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,850

F2 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. The sales reported herein were effected in order to satisfy the costs of exercise and the required income tax withholdings.

Read SEC document
September 14, 2021 Filed Sep 16, 2021 22:07 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock (right to purchase) · Derivative 52,000 $0.30 Strike: $0.30 $15,600.00
Disclosure

SEC source: 0001209191-21-056457 · doc4.xml · derivative · entry 6

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 52,000 shares

Expires 2022-11-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. Subsequent to exercise, he plans to sell some of the shares exercised in order to satisfy the costs of exercise and the required income tax withholdings.

F4 · derivative.exercise_date: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Read SEC document
September 14, 2021 Filed Sep 16, 2021 22:07 UTC
Cureton KevinChief Operating Officer
SaleCommon Stock 2,800 $2.30 $6,440.00
Disclosure

SEC source: 0001209191-21-056457 · doc4.xml · nonDerivative · entry 2

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,200

F2 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. The sales reported herein were effected in order to satisfy the costs of exercise and the required income tax withholdings.

Read SEC document
September 14, 2021 Filed Sep 16, 2021 22:07 UTC
Cureton KevinChief Operating Officer
Exercise / conversionCommon Stock 52,000 $0.30 $15,600.00
Disclosure

SEC source: 0001209191-21-056457 · doc4.xml · nonDerivative · entry 1

Cureton Kevin · CIK 0001563513 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Mr. Cureton has exercised shares from his November 28, 2012 option grant to avoid the risk of expiration. In light of the blackout requirements within the Company's Policy on Insider Trading, limited trading windows exist during which these transactions can be completed. Subsequent to exercise, he plans to sell some of the exercised shares reported herein in order to satisfy the costs of exercise and the required income tax withholdings.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.